Varenicline for Gait and Balance Impairment in Parkinson Disease
Trial
Phase 2
Completed
Dec. 29, 2022
Validation of Dyskinesia Rating Scales
Trial
Phase 4
Completed
Dec. 28, 2022
Amitiza in Constipation Associated With PD (Parkinson's Disease)
Trial
Phase 4
Completed
Dec. 28, 2022
Femoral Cartilage Thickness in Parkinson's Disease
Trial
N/A
Completed
Dec. 26, 2022
Vibrotactile Coordinated Reset: A Non-invasive Treatment for Parkinson's Disease
Trial
N/A
Terminated
Dec. 26, 2022
Evaluation of Clinical Progression in Patients With Motor Predominant Parkinson Disease.
Trial
N/A
Terminated
Dec. 20, 2022
A Study of an Investigational Drug to See How it Affects the People With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes) Compared to an Approved Drug Used to Treat People With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes)
Trial
Phase 3
Completed
Dec. 15, 2022
Namenda (Memantine) for Non-motor Symptoms in Parkinson's Disease
Trial
Phase 4
Completed
Dec. 12, 2022
Use of BART Coupled With EEG in the Early Diagnosis of Behavioral Disorders in Parkinson's Disease
Trial
N/A
Unknown
Dec. 11, 2022
The Effects of Telerehabilitation-based Exercise Trainings on Gait and Balance in Parkinson's Patients
Trial
N/A
Completed
Dec. 8, 2022
Exergames in In-patient Rehabilitation
Trial
N/A
Completed
Dec. 8, 2022
Effects of Home Rehabilitation of Balance Based on Functional Exercises in People With Parkinson's Disease
Trial
N/A
Unknown
Dec. 7, 2022
The Effect of Multi-target Magnetic Stimulation on Freezing Gait in PD
Trial
N/A
Unknown
Dec. 5, 2022
Open Label Continuation Treatment Study With Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease
Trial
Phase 3
Completed
Dec. 1, 2022
Neuromelanin MRI: A Progression Marker in Early PD
Trial
N/A
Unknown
Nov. 29, 2022
Benefits of Different Exercise Types to Enhance Walking for PD
Trial
N/A
Unknown
Nov. 29, 2022
Differential Diagnosis Between Parkinson's Disease and Multiple System Atrophy Using Digital Speech Analysis
Trial
N/A
Completed
Nov. 27, 2022
Opicapone Treatment Initiation Open-Label Study
Trial
N/A
Completed
Nov. 27, 2022
Towards the Use of Instrumented Tests for Screening the Risk of Falling in Patients With Chronic Illness.
Trial
N/A
Completed
Nov. 20, 2022